140 related articles for article (PubMed ID: 16643879)
21. Biopsy of cervical lymph node.
Matsumoto F; Itoh S; Ohba S; Yokoi H; Furukawa M; Ikeda K
Auris Nasus Larynx; 2009 Feb; 36(1):71-4. PubMed ID: 18479855
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
Senden D; Buchet JP; Lauwerys R
J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
[TBL] [Abstract][Full Text] [Related]
23. Circadian variations of interleukin-2 receptors, serum thymidine kinase and beta-2-microglobulin in patients with non-Hodgkin's lymphoma and normal controls.
Micke O; Schäfer U; Wörmann B; Hiddemann W; Willich N
Anticancer Res; 1997; 17(4B):3007-10. PubMed ID: 9329587
[TBL] [Abstract][Full Text] [Related]
24. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
Kvist E; Sjølin KE; Iversen J
Scand J Urol Nephrol; 1990; 24(4):287-92. PubMed ID: 2274753
[TBL] [Abstract][Full Text] [Related]
25. Results of the determination of serum markers in patients with malignant melanoma.
Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
[TBL] [Abstract][Full Text] [Related]
26. [Tumor markers in malignant lymphoma].
Banno S; Ueda R
Gan To Kagaku Ryoho; 2002 Jan; 29(1):149-53. PubMed ID: 11816473
[TBL] [Abstract][Full Text] [Related]
27. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
28. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
29. Serum lactate dehydrogenase is a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis.
Yun SJ; Choi MS; Piao MS; Lee JB; Kim SJ; Won YH; Lee SC
Dermatology; 2008; 217(3):254-9. PubMed ID: 18667824
[TBL] [Abstract][Full Text] [Related]
30. Relevance of some serum biomarkers (E cadherin, GAGs & MDA in patients with diffuse large B-cell lymphoma.
Eissa LA; Esmaeel MI
Pak J Pharm Sci; 2008 Jan; 21(1):29-35. PubMed ID: 18166516
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
32. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
33. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
34. Treatment results of chemoradiation therapy for localized aggressive lymphomas: A retrospective 20-year study.
Yamashita H; Izutsu K; Nakamura N; Shiraishi K; Chiba S; Kurokawa M; Tago M; Igaki H; Ohtomo K; Nakagawa K
Ann Hematol; 2006 Aug; 85(8):523-9. PubMed ID: 16691398
[TBL] [Abstract][Full Text] [Related]
35. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
37. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
[TBL] [Abstract][Full Text] [Related]
38. [Assay of serum beta 2-microglobulin in patients with malignant hematologic diseases and its clinical significance].
Zhong M; Liu W
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(3):277-8. PubMed ID: 9868137
[No Abstract] [Full Text] [Related]
39. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract][Full Text] [Related]
40. Urinary excretion of pseudouridine and prognosis of patients with malignant lymphoma.
Rasmuson T; Björk GR
Acta Oncol; 1995; 34(1):61-7. PubMed ID: 7865238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]